BPA for joenja and ruconest

Active Awarded Last action

Contract number
36E79724A0010
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
  • VA797P12Q0002 Solicitation number
Last date to order 87% complete
IDV ceiling
$900,000.00
Award type
Single award
Who can order
Only the awarding agency
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

This Blanket Purchase Agreement (BPA), awarded on March 13, 2024, by the National Acquisition Center to Pharming Healthcare, Inc., establishes a single-award indefinite delivery vehicle for the supply of pharmaceutical products, specifically Joenja and Ruconest. The contract operates under the General Services Administration's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and carries a ceiling value of $900,000.00. This represents the exercise of Option Year 2 under the original BPA 36E79724A0010, demonstrating an ongoing procurement relationship for these specialized pharmaceutical agents. The agreement will remain active through March 12, 2027, providing the government with a pre-established mechanism for ordering these medications as needed without further competition.

Joenja and Ruconest are biopharmaceutical products indicated for rare bleeding disorders, with Ruconest being a plasma-derived C1-esterase inhibitor used for hereditary angioedema and Joenja representing another hemostasis-related therapeutic. As a civilian agency BPA with no set-aside provisions, this procurement allows the National Acquisition Center to efficiently manage pharmaceutical supply requirements for these critical specialty medications. The single-award structure indicates that Pharming Healthcare, Inc. is the sole source provider under this vehicle, streamlining the ordering process for government entities requiring these pharmaceuticals while maintaining price certainty and supply continuity throughout the contract period.

Transactions

Action Obligated Date
Exercise an Option P00004 · Exercise option year 2 - BPA 36E79724A0010 $0
Supplemental Agreement for work within scope P00003 · 2026 public law pricing updates. $0
Exercise an Option P00002 · This modification is issued to exercise option year 1 on BPA 36E79724A0010. $0
Supplemental Agreement for work within scope P00001 · 2025 public law pricing updates. $0
Original award $0

Quick answers

Who was awarded contract 36E79724A0010?

36E79724A0010 was awarded to Pharming Healthcare, Inc. by National Acquisition Center (Headquarters) on March 13, 2024.

How much is contract 36E79724A0010 worth?

36E79724A0010's own ceiling is $900,000.

Who can order from contract 36E79724A0010?

36E79724A0010 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.

Is contract 36E79724A0010 under another contract?

Yes. 36E79724A0010 is a blanket purchase agreement under 36F79718D0396, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36E79724A0010 competed?

The extent of competition for 36E79724A0010 was full and open competition. The government received 1 offer.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV